OLDAKOWSKI JOSEPH FRANK
Known title: VP OF FINANCE AND CONTROLLERCIK: 0002128814
Associated companies
Transaction History
| CLOV | ▼ Sell | Open Market | 3,170 | $15K | 9/16/2026 | View on chart |
| CLOV | ▼ Sell | Open Market | 20,000 | $103K | 9/14/2026 | View on chart |
| CLOV | ▼ Sell | Open Market | 12,102 | $59K | 6/16/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Clover Health Gains After Earning 5-Star CMS Rating
Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.
Clover Health Gains After Earning 5-Star CMS Rating. Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.